Most Recent
Internet search giant Google wants to weigh in on an appeal over whether Epic Games' lawsuit accusing Apple of abusing its dominance in the app store marketplace should be heard in Australia, as the ACCC wins its bid to intervene in the case.
HWL Ebsworth has been ordered to hand over file notes to a former client and whistleblower suing ANZ for unfair dismissal, with a judge rejecting the law firm's argument that the notes were created solely for the benefit of the junior solicitor taking them.
Generic drug company Pharmacor has fired back in a patent lawsuit by Novartis, filing a cross-claim seeking to invalidate the Swiss drug giant's patents for its blockbuster MS drug Gilenya.
A unit of coal mining company Futura Resources has failed to convince the Full Federal Court to allow it to register a 2012 coking coal mine investigation conducted in Central Queensland for a research and development tax offset.
The Commonwealth Bank of Australia is resisting a novel proposal by ASIC to use its CommBank app to notify 6.3 million customers of a $7 million fine against it for overcharging interest, saying the move would pose a "significant risk" to the public.
Westpac will recoup the majority of proceeds from the $29.6 million sale of collapsed fintech Sargon Group, with a judge calling the company's liquidators "anxious sellers" who sold at speed and well below market value.
Fortnite game maker Epic Games has appealed a judge's decision to send its misuse of market power case against Apple to California, in a significant case with implications for whether Australian companies can litigate disputes with tech giants on their home turf.
Pasta distributor Conga Foods is challenging a ruling that dashed its bid to register its 'La Famiglia Rana' trade mark in Australia.
The High Court has granted special leave to hear a first-of-its-kind dispute over a number of airplane engines leased by the beleaguered Virgin Airlines, which may result in the airline’s administrators using company funds to cover the costs of shipping the engines back to Florida.
Swiss drug giant Novartis has secured an injunction temporarily blocking drug maker Pharmacor from launching a generic version of the company’s top-selling MS drug Gilenya in Australia.